Toolgen’s AAV delivery could move CRISPR/Cas9 beyond genetic disease – BioWorld Online
|
Toolgen's AAV delivery could move CRISPR/Cas9 beyond genetic disease
BioWorld Online SHANGHAI – In the midst of a busy news week for CRISPR/Cas9 – a powerful tool that gives cut-and-paste accuracy to gene editing by using adapted immune bacteria – Toolgen Inc. has made advances of its own. The Seoul, South Korea-based company … |
